Early onset Rasmussen's syndrome: a malignant, often bilateral form of the disorder

Frederick Andermann1, Kevin Farrell

  • 1Montreal Neurological Hospital & Institute, 3801 University Street, Room 127, Montreal, Que. H3A 2B4, Canada. frederick.Andermann@mcgill.ca

Epilepsy Research
|July 11, 2006
PubMed

Insights

Early onset Rasmussen's syndrome in children often leads to bilateral brain disease, a severe condition with a poor prognosis. This contrasts with adult cases, which may have a better outlook.

Area of Science:

  • Neurology
  • Pediatric Neurology
  • Neuroimmunology

Background:

  • Rasmussen's syndrome (RS) is a rare, chronic inflammatory neurological disease affecting the brain.
  • Early-onset RS in children is increasingly recognized for its tendency towards bilateral cerebral hemisphere involvement.
  • The prognosis of RS varies significantly based on age of onset and disease laterality.

Purpose of the Study:

  • To describe a cohort of children with early-onset Rasmussen's syndrome and bilateral disease.
  • To investigate the clinical characteristics and prognosis of pediatric bilateral RS.
  • To compare the presentation and outcomes of bilateral RS in children versus adults.

Main Methods:

  • Retrospective case series analysis of children diagnosed with Rasmussen's syndrome.
  • Clinical data review including neurological examination, seizure patterns, and neuroimaging.
  • Comparison with previously reported adult cases of Rasmussen's syndrome.

Main Results:

  • A cluster of children with early-onset Rasmussen's syndrome exhibited a marked tendency for bilateral brain involvement.
  • This pediatric bilateral form of the disease presented with a poor prognosis, often proving fatal.
  • Bilateral involvement in adults, unlike bilateral epileptic discharges, appears to have a more favorable prognosis.

Conclusions:

  • Early-onset Rasmussen's syndrome with bilateral involvement in children represents a distinct and severe clinical entity.
  • Immune system immaturity may contribute to the aggressive bilateral progression in pediatric cases.
  • Further research is needed to understand the impact of immunomodulatory treatments on contralateral spread in Rasmussen's syndrome.

Related Concept Videos

Rocky Mountain Spotted Fever01:26

Rocky Mountain Spotted Fever

Rocky Mountain Spotted Fever (RMSF) is a severe tick-borne illness caused by Rickettsia rickettsii, a Gram-negative, coccobacillary bacterium. This pathogen is an obligate intracellular parasite, requiring a host cell for replication. Transmission occurs through the bite of an infected tick. In the United States, the most important vectors are Dermacentor variabilis (American dog tick) and Dermacentor andersoni (Rocky Mountain wood tick), though other tick species may also serve as vectors.
Rabies01:28

Rabies

Rabies is a lethal zoonotic disease caused by a single-stranded, negative-sense RNA virus of the Lyssavirus genus, within the family Rhabdoviridae. Its primary mode of transmission to humans is through bites or saliva-contaminated scratches from infected mammals such as dogs, bats, raccoons, or foxes. Transmission can also occur if infectious saliva contacts abraded skin or intact mucous membranes, including the conjunctiva.Viral Entry and Early ReplicationOnce introduced at the bite or scratch...
Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...